11.100
−0,89%
2026-10-19
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +63.4% | +83.8% | 3 / 3 | -3.1% | +5.04 pp | +5.76 pp | +10.3% | 0.01 | 6.19 | 37,9 | −3,1% | 5,9 | +54,1% | 6.19 | 11.41 | −45,8% |
| Pts | 12 | 12 | 12 | 0 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 11.100 (close price on 2026-10-19)EPS (TTM): 1.794
Financial charts
1.Revenue & growth
VND bn37,9Q2/26
1.Revenue & growth
VND bn37,9Q2/26
2.Profit & growth
VND bn5,72Q2/26
3.Profit mix (Penman)
VND bn23,3Q2/26
4.Margins & cost structure
%52.6%Q2/26
5.Returns & cash cycle
% · days13.6%Q2/26
6.Earnings quality & cash
VND bn14,1Q2/26
7.Asset structure
VND bn241Q2/26
8.Funding & debt health
VND bn · times241Q2/26
9.Revenue backlog
VND bn3,20Q2/26
10.Valuation
times · %6,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %477Q2/26
Adjusted EPS growth, latest quarter
57.3%
Average adjusted EPS growth, 3 quarters
81.8%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26